Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models

卷:12

Article

关键词: SIGNAL TRANSDUCER VAV1;    CELL-RECEPTOR SIGNALS;    EXCHANGE FACTOR VAV1;    TYROSINE PHOSPHORYLATION;    PROTOONCOGENE PRODUCT;    RHO GTPASES;    LUNG-CANCER;    C1 DOMAINS;    SH2 DOMAIN;    WILD-TYPE;   

DOI  :  10.3390/cells12091276

来源: SCIE

【 摘 要 】

VAV1 is a hematopoietic signal transducer that possesses a GDP/GTP nucleotide exchange factor (GEF) that is tightly regulated by tyrosine phosphorylation, along with adapter protein domains, such as SH2 and SH3. Research on VAV1 has advanced over the years since its discovery as an in vitro activated oncogene in an NIH3T3 screen for oncogenes. Although the oncogenic form of VAV1 first identified in the screen has not been detected in human clinical tumors, its wild-type and mutant forms have been implicated in mammalian malignancies of various tissue origins, as well as those of the hematopoietic system. This review article addresses the activity of human VAV1 as an overexpressed or mutated gene and also describes the differences in the distribution of VAV1 mutations in the hematopoietic system and in other tissues. The knowledge accumulated thus far from GEMMs expressing VAV1 is described, with the conclusion that GEMMs of both wild-type VAV1 and mutant VAV1 do not form tumors, yet these will be generated when additional molecular insults, such as loss of p53 or KRAS mutation, occur.